UBS upgrades Smith & Nephew to 'buy'
23rd Jun 2015 08:25
UBS upgraded Smith & Nephew to 'buy' from 'neutral' and raised the target price to 1,275p from 1,175p. "Our channel checks with wound nurses and industry experts lead us to believe that Smith & Nephew's wound division is currently operating below its potential," said UBS. It now sees scope for divis
Read moreLondon midday: Bond jitters weigh on stocks
4th Jun 2015 11:54
UK stocks edged lower following recent volatility in sovereign debt markets and amid mixed reports on the progress made at a meeting between Greek Prime Minister Alexis Tsipras and the head of the European Commission, Jean Claude Juncker. As of 12:21 the FTSE 100 was lower by 95.23 points to 6,855.2
Read moreLondon open: European bond yields keep rising, stocks down
4th Jun 2015 08:48
Stocks began the morning moving lower amid mixed reports regarding the progress made at a meeting between Greek Prime Minister Alexis Tsipras and the head of the European Commission, Jean Claude Juncker. As of 08:55 the FTSE 100 was lower by 87.36 points to 6,863.10. A large drop in Chinese stocks
Read moreLondon pre-open: Stocks to slide lower amid concerns over bonds, market volatility, Greece
4th Jun 2015 07:21
Blue chips are headed for a drop early on in Thursday's session, reversing the gains seen on Wednesday as concern about the bond market and predictions from the European Central Bank (ECB) that market volatility will persist weigh on investor sentiment. City sources predict the FTSE 100 will open ar
Read moreSmith & Nephew to remove hip device from market
4th Jun 2015 07:01
Medical technology group Smith & Nephew has chosen to remove one of its hip devices from the market, based on recent performance data. The removed device and its corresponding components accounted for around 1% of the company's global hip implant revenue in 2014, and 0.1% of group revenues and as su
Read moreLondon close: Stocks edge higher despite mixed earnings, data
30th Apr 2015 16:23
UK stocks managed to erase earlier losses to settle in positive territory on Thursday as investors picked up bargains following heavy losses over the last two sessions. The FTSE 100 finished 0.21% higher at 6,960.63, bouncing back after hitting a low of 6,906.24 early on amid a mixed batch of corpor
Read moreLondon midday: Stocks erase losses but weak earnings limit upside
30th Apr 2015 12:02
Uncertainty surrounding US monetary policy and a raft of poorly-received corporate earnings kept the FTSE 100 flat on Thursday morning, with the index fluctuating at its lowest in three weeks. The FTSE 100 was up just 0.09% at 6,952.66 by midday, with RBS, IAG and Schroders limiting upside after dis
Read moreSmith & Nephew reiterates annual guidance but warns of currency headwinds
30th Apr 2015 08:08
Medical services group Smith & Nephew reported a slight increase in first quarter revenue and reiterated its expectations for 2015. However, the FTSE 100 group said the strong dollar weighed on its performances in the first three months of the year, estimating a hit of approximately 8%, and warned i
Read moreMonday broker round-up
30th Mar 2015 18:40
Carnival: Numis upgrades to add with target price of 3,600p, Credit Suisse keeps at outperform, while Jefferies stays at underperform with 2,300p target. Barclays: JP Morgan Cazenove reiterates overweight. WPP: UBS reiterates buy, ups target to 1,700p from 1,500p. Marks&Spencer: Credit Suisse impr
Read moreBroker tips: Standard Chartered, Carnival, Smith & Nephew, Weir
23rd Mar 2015 12:24
UK listed bank Standard Chartered has had its rating promoted to 'overweight' from 'neutral' at JPMorgan. The US bank said that although it is hesitant to change its view for the arrival of the new chief executive which has been a material positive, "we believe that last week's UK budget may lead th
Read moreSmith & Nephew raised to 'buy' at Goldman Sachs
23rd Mar 2015 09:21
Smith & Nephew has been raised to 'buy' from 'neutral' at Goldman Sachs on Monday due to improving fundamentals and under-appreciated strategic value. Goldman also increased its target price on the stock, up to 1300p from 1200p. The bank said Smith & Nephew's stock has been a notable under-performe
Read moreBroker tips: Tullow Oil, Smith & Nephew, Johnson Matthey, Cairn Energy
11th Mar 2015 11:33
Westhouse Securities has maintained a 'buy' recommendation on Tullow after the oil producer and explorer delivered a positive update on its appraisal programme in Kenya. "Tullow is now trading at an unprecedented 36% discount to our core net asset value [forecast] despite having high margin producti
Read moreJPMorgan expects M&A premium at Smith & Nephew to unwind as Stryker hopes fade
11th Mar 2015 11:05
The M&A premium factored into the price of Smith & Nephew (S&N) will likely start to unwind, according to JPMorgan Cazenove, which said that a takeover by US medical devices peer Stryker is now "unlikely". The bank retained a 'neutral' rating and 1,040p target price on the UK stock. Last week's ann
Read moreLondon close: Mixed data, weak earnings pull FTSE below 6,900
3rd Mar 2015 16:33
A mixed batch of economic data and weak corporate earnings gave investors the excuse to take profits on Tuesday, as markets continued to retreat from their recent record highs. London's FTSE 100, which had started the day in positive territory, swung sharply into the red by mid-morning and extended
Read moreSmith&Nephew continues spree of purchases in emerging markets
3rd Mar 2015 14:31
Medical device-marker Smith&Nephew continues to snap-up assets in emerging markets. The FTSE 100-listed firm on Tuesday announced the purchase of EuroCiencia Colombia, its sole distributor for orthopaedic reconstruction, trauma and sports medicine products in that South American country. The terms
Read more